OBJECTIVE: With 2.3 million breast cancer survivors in the US today, identification of modifiable factors associated with breast cancer recurrence and survival is increasingly important. Only recently new studies have been designed to examine the impact of lifestyle factors on prognosis, including Pathways, a prospective study of women with breast cancer in Kaiser Permanente Northern California (KPNC). METHODS: Pathways aims to examine the effect on recurrence and survival of (1) lifestyle factors such as diet, physical activity, quality of life, and use of alternative therapies and (2) molecular factors such as genetic polymorphisms involved in metabolism of chemotherapeutic agents. Eligibility includes any woman diagnosed with invasive breast cancer within KPNC, no previous diagnosis of other invasive cancer, age 21 years or older, and ability to speak English, Spanish, Cantonese, or Mandarin. Newly diagnosed patients are identified daily from electronic pathology records and are enrolled within two months of diagnosis. An extensive baseline interview is conducted, blood and saliva samples are collected, and body measurements are taken. Women are followed for lifestyle updates, treatment, and outcomes by self-report and query of KPNC databases. RESULTS: Recruitment began in 9 January, 2006, and as of 16 January, 2008, 1,539 women have been enrolled along with collection of 1,323 blood samples (86%) and 1,398 saliva samples (91%). CONCLUSIONS: The Pathways Study will become a rich resource to examine behavioral and molecular factors and breast cancer prognosis.
OBJECTIVE: With 2.3 million breast cancer survivors in the US today, identification of modifiable factors associated with breast cancer recurrence and survival is increasingly important. Only recently new studies have been designed to examine the impact of lifestyle factors on prognosis, including Pathways, a prospective study of women with breast cancer in Kaiser Permanente Northern California (KPNC). METHODS: Pathways aims to examine the effect on recurrence and survival of (1) lifestyle factors such as diet, physical activity, quality of life, and use of alternative therapies and (2) molecular factors such as genetic polymorphisms involved in metabolism of chemotherapeutic agents. Eligibility includes any woman diagnosed with invasive breast cancer within KPNC, no previous diagnosis of other invasive cancer, age 21 years or older, and ability to speak English, Spanish, Cantonese, or Mandarin. Newly diagnosed patients are identified daily from electronic pathology records and are enrolled within two months of diagnosis. An extensive baseline interview is conducted, blood and saliva samples are collected, and body measurements are taken. Women are followed for lifestyle updates, treatment, and outcomes by self-report and query of KPNC databases. RESULTS: Recruitment began in 9 January, 2006, and as of 16 January, 2008, 1,539 women have been enrolled along with collection of 1,323 blood samples (86%) and 1,398 saliva samples (91%). CONCLUSIONS: The Pathways Study will become a rich resource to examine behavioral and molecular factors and breast cancer prognosis.
Authors: Yali A Bair; Ellen B Gold; Gail A Greendale; Barbara Sternfeld; Shelley R Adler; Rahman Azari; Martha Harkey Journal: Am J Public Health Date: 2002-11 Impact factor: 9.308
Authors: L K Staten; D L Taren; W H Howell; M Tobar; E T Poehlman; A Hill; P M Reid; C Ritenbaugh Journal: Med Sci Sports Exerc Date: 2001-11 Impact factor: 5.411
Authors: Wei Lu; Yong Cui; Ying Zheng; Kai Gu; Hui Cai; Qiong Li; Wei Zheng; Xiao Ou Shu Journal: Breast Cancer Res Treat Date: 2006-07-19 Impact factor: 4.872
Authors: Colleen Doyle; Lawrence H Kushi; Tim Byers; Kerry S Courneya; Wendy Demark-Wahnefried; Barbara Grant; Anne McTiernan; Cheryl L Rock; Cyndi Thompson; Ted Gansler; Kimberly S Andrews Journal: CA Cancer J Clin Date: 2006 Nov-Dec Impact factor: 508.702
Authors: Marilie D Gammon; Alfred I Neugut; Regina M Santella; Susan L Teitelbaum; Julie A Britton; Mary Beth Terry; Sybil M Eng; Mary S Wolff; Steven D Stellman; Geoffrey C Kabat; Bruce Levin; H Leon Bradlow; Maureen Hatch; Jan Beyea; David Camann; Martin Trent; Ruby T Senie; Gail C Garbowski; Carla Maffeo; Pat Montalvan; Gertrud S Berkowitz; Margaret Kemeny; Marc Citron; Freya Schnabe; Allan Schuss; Steven Hajdu; Vincent Vincguerra; Gwen W Collman; G Iris Obrams Journal: Breast Cancer Res Treat Date: 2002-06 Impact factor: 4.872
Authors: Anita L Stewart; Anna M Nápoles-Springer; Steven E Gregorich; Jasmine Santoyo-Olsson Journal: Health Serv Res Date: 2007-06 Impact factor: 3.402
Authors: Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark Journal: N Engl J Med Date: 2002-10-17 Impact factor: 91.245
Authors: Marilyn L Kwan; Barbara Sternfeld; Isaac Joshua Ergas; Allegra W Timperi; Janise M Roh; Chi-Chen Hong; Charles P Quesenberry; Lawrence H Kushi Journal: Breast Cancer Res Treat Date: 2011-09-28 Impact factor: 4.872
Authors: Marilyn L Kwan; Jeanne Darbinian; Kathryn H Schmitz; Rebecca Citron; Paula Partee; Susan E Kutner; Lawrence H Kushi Journal: Arch Surg Date: 2010-11
Authors: Xifeng Wu; Michelle At Hildebrandt; Yuanqing Ye; Wong-Ho Chow; Jian Gu; Sonia Cunningham; Hua Zhao; Ernest T Hawk; Elizabeth Wagar; Alma Rodriguez; Stanley R Hamilton Journal: Int J Epidemiol Date: 2015-12-20 Impact factor: 7.196
Authors: Devon K Check; Marilyn L Kwan; Neetu Chawla; Stacie B Dusetzina; Emily Valice; Isaac J Ergas; Janise M Roh; Tatjana Kolevska; Donald L Rosenstein; Lawrence H Kushi Journal: J Pain Symptom Manage Date: 2018-12-01 Impact factor: 3.612
Authors: Devon K Check; Neetu Chawla; Marilyn L Kwan; Laura Pinheiro; Janise M Roh; Isaac J Ergas; Anita L Stewart; Tatjana Kolevska; Christine Ambrosone; Lawrence H Kushi Journal: Breast Cancer Res Treat Date: 2018-04-05 Impact factor: 4.872
Authors: Carol Sweeney; Philip S Bernard; Rachel E Factor; Marilyn L Kwan; Laurel A Habel; Charles P Quesenberry; Kaylynn Shakespear; Erin K Weltzien; Inge J Stijleman; Carole A Davis; Mark T W Ebbert; Adrienne Castillo; Lawrence H Kushi; Bette J Caan Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-02-12 Impact factor: 4.254
Authors: Bette J Caan; Carol Sweeney; Laurel A Habel; Marilyn L Kwan; Candyce H Kroenke; Erin K Weltzien; Charles P Quesenberry; Adrienne Castillo; Rachel E Factor; Lawrence H Kushi; Philip S Bernard Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-02-12 Impact factor: 4.254